Dr. John Doyle, MD
Claim this profileCancerCare Manitoba
Studies Neuroblastoma
1 reported clinical trial
1 drug studied
Clinical Trials John Doyle, MD is currently running
More about John Doyle, MD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments John Doyle, MD has experience with
- Eflornithine
Breakdown of trials John Doyle, MD has run
Neuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Doyle, MD specialize in?
John Doyle, MD focuses on Neuroblastoma and other conditions. In particular, much of their work with Neuroblastoma has involved treating patients, or patients who are undergoing treatment.
Is John Doyle, MD currently recruiting for clinical trials?
Yes, John Doyle, MD is currently recruiting for 1 clinical trial in Winnipeg Manitoba. If you're interested in participating, you should apply.
Are there any treatments that John Doyle, MD has studied deeply?
Yes, John Doyle, MD has studied treatments such as Eflornithine.
What is the best way to schedule an appointment with John Doyle, MD?
Apply for one of the trials that John Doyle, MD is conducting.
What is the office address of John Doyle, MD?
The office of John Doyle, MD is located at: CancerCare Manitoba, Winnipeg, Manitoba Canada. This is the address for their practice at the CancerCare Manitoba.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.